Skip to main content
NCBI home page
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 1997;5(2):133–141. doi: 10.1155/S1064744997000215

Pathogenesis of HSV and CMV Infections in Pregnancy

Myriam Askienazy-Elbhar 1, Christophe Sifer 2
PMCID: PMC2364558  PMID: 18476166

Abstract

Human herpesvirus (HHSV) and human cytomegalovirus (HCMV) infections during pregnancy are a major concern of public health because of the risk for severe sequelae for the fetuses and the neonates and because primary infections, reinfections and reactivations can be asymptomatic. The risk for neonatal herpes is mostly congenital, while the risk for HCMV infection is either prenatal or congenital. Screening exposed women has not brought definite solutions but is currently being evaluated. Among pregnant women with active infection, evaluation of the fetus for contamination and thus for the risk for severe immediate or long-term sequelae for neonates is the major goal. Diagnostic tools are available, cell culture still being the gold standard, and polymerase chain reaction (PCR) being currently evaluated for its contribution to diagnosis of active infection. Consensus for screening pregnant women as well as achievement of antiviral vaccines are the most urgent intervention strategies to develop in the near future.

Full Text

The Full Text of this article is available as a PDF (820.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahlfors K., Forsgren M., Ivarsson S. A., Harris S., Svanberg L. Congenital cytomegalovirus infection: on the relation between type and time of maternal infection and infant's symptoms. Scand J Infect Dis. 1983;15(2):129–138. doi: 10.3109/inf.1983.15.issue-2.01. [DOI] [PubMed] [Google Scholar]
  2. Ashraf S. J., Parande C. M., Arya S. C. Cytomegalovirus antibodies of patients in the Gizan area of Saudi Arabia. J Infect Dis. 1985 Dec;152(6):1351–1351. doi: 10.1093/infdis/152.6.1351. [DOI] [PubMed] [Google Scholar]
  3. Balachandran N., Bacchetti S., Rawls W. E. Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2. Infect Immun. 1982 Sep;37(3):1132–1137. doi: 10.1128/iai.37.3.1132-1137.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Berman P. W., Dowbenko D., Lasky L. A., Simonsen C. C. Detection of antibodies to herpes simplex virus with a continuous cell line expressing cloned glycoprotein D. Science. 1983 Nov 4;222(4623):524–527. doi: 10.1126/science.6312563. [DOI] [PubMed] [Google Scholar]
  5. Boggess K. A., Watts D. H., Hobson A. C., Ashley R. L., Brown Z. A., Corey L. Herpes simplex virus type 2 detection by culture and polymerase chain reaction and relationship to genital symptoms and cervical antibody status during the third trimester of pregnancy. Am J Obstet Gynecol. 1997 Feb;176(2):443–451. doi: 10.1016/s0002-9378(97)70513-1. [DOI] [PubMed] [Google Scholar]
  6. Boppana S. B., Pass R. F., Britt W. J., Stagno S., Alford C. A. Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J. 1992 Feb;11(2):93–99. doi: 10.1097/00006454-199202000-00007. [DOI] [PubMed] [Google Scholar]
  7. Boué A., Cabau N. Epidémiologie des infections par le cytomégalovirus. Nouv Presse Med. 1978 Oct 14;7(35):3135–3139. [PubMed] [Google Scholar]
  8. Brown Z. A., Benedetti J., Ashley R., Burchett S., Selke S., Berry S., Vontver L. A., Corey L. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med. 1991 May 2;324(18):1247–1252. doi: 10.1056/NEJM199105023241804. [DOI] [PubMed] [Google Scholar]
  9. Cabau N., Labadie M. D., Vesin C., Feingold J., Boué A. Seroepidemiology of cytomegalovirus infections during the first years of life in urban communities. Arch Dis Child. 1979 Apr;54(4):286–290. doi: 10.1136/adc.54.4.286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Chandler S. H., Handsfield H. H., McDougall J. K. Isolation of multiple strains of cytomegalovirus from women attending a clinic for sexually transmitted disease. J Infect Dis. 1987 Apr;155(4):655–660. doi: 10.1093/infdis/155.4.655. [DOI] [PubMed] [Google Scholar]
  11. Demmler G. J. Infectious Diseases Society of America and Centers for Disease Control. Summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev Infect Dis. 1991 Mar-Apr;13(2):315–329. doi: 10.1093/clinids/13.2.315. [DOI] [PubMed] [Google Scholar]
  12. Douglas J., Schmidt O., Corey L. Acquisition of neonatal HSV-1 infection from a paternal source contact. J Pediatr. 1983 Dec;103(6):908–910. doi: 10.1016/s0022-3476(83)80711-2. [DOI] [PubMed] [Google Scholar]
  13. Dussaix E., Chantot S., Harzic M., Grangeot-Keros L. CMV-IGG avidity and CMV-IGM concentration in both immunocompromised and immunocompetent patients. Pathol Biol (Paris) 1996 May;44(5):405–410. [PubMed] [Google Scholar]
  14. Dworsky M., Yow M., Stagno S., Pass R. F., Alford C. Cytomegalovirus infection of breast milk and transmission in infancy. Pediatrics. 1983 Sep;72(3):295–299. [PubMed] [Google Scholar]
  15. Ekwo E., Wong Y. W., Myers M. Asymptomatic cervicovaginal shedding of herpes simplex virus. Am J Obstet Gynecol. 1979 May 1;134(1):102–103. doi: 10.1016/0002-9378(79)90804-4. [DOI] [PubMed] [Google Scholar]
  16. Fan-Havard P., Nahata M. C., Brady M. T. Ganciclovir--a review of pharmacology, therapeutic efficacy and potential use for treatment of congenital cytomegalovirus infections. J Clin Pharm Ther. 1989 Oct;14(5):329–340. doi: 10.1111/j.1365-2710.1989.tb00256.x. [DOI] [PubMed] [Google Scholar]
  17. Fowler K. B., Stagno S., Pass R. F., Britt W. J., Boll T. J., Alford C. A. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med. 1992 Mar 5;326(10):663–667. doi: 10.1056/NEJM199203053261003. [DOI] [PubMed] [Google Scholar]
  18. Goff E., Griffith B. P., Booss J. Delayed amplification of cytomegalovirus infection in the placenta and maternal tissues during late gestation. Am J Obstet Gynecol. 1987 May;156(5):1265–1270. doi: 10.1016/0002-9378(87)90159-1. [DOI] [PubMed] [Google Scholar]
  19. Griffiths P. D., Stagno S., Pass R. F., Smith R. J., Alford C. A., Jr Infection with cytomegalovirus during pregnancy: specific IgM antibodies as a marker of recent primary infection. J Infect Dis. 1982 May;145(5):647–653. doi: 10.1093/infdis/145.2.647. [DOI] [PubMed] [Google Scholar]
  20. Hatherley L. I., Hayes K., Jack I. Herpes virus in an obstetric hospital. II: Asymptomatic virus excretion in staff members. Med J Aust. 1980 Sep 6;2(5):273–275. [PubMed] [Google Scholar]
  21. Hayward G. S., Jacob R. J., Wadsworth S. C., Roizman B. Anatomy of herpes simplex virus DNA: evidence for four populations of molecules that differ in the relative orientations of their long and short components. Proc Natl Acad Sci U S A. 1975 Nov;72(11):4243–4247. doi: 10.1073/pnas.72.11.4243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Herold B. C., WuDunn D., Soltys N., Spear P. G. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J Virol. 1991 Mar;65(3):1090–1098. doi: 10.1128/jvi.65.3.1090-1098.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Honess R. W., Roizman B. Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J Virol. 1974 Jul;14(1):8–19. doi: 10.1128/jvi.14.1.8-19.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kamada M., Komori A., Chiba S., Nakao T. A prospective study of congenital cytomegalovirus infection in Japan. Scand J Infect Dis. 1983;15(3):227–232. doi: 10.3109/inf.1983.15.issue-3.01. [DOI] [PubMed] [Google Scholar]
  25. Kieff E. D., Bachenheimer S. L., Roizman B. Size, composition, and structure of the deoxyribonucleic acid of herpes simplex virus subtypes 1 and 2. J Virol. 1971 Aug;8(2):125–132. doi: 10.1128/jvi.8.2.125-132.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kimura H., Futamura M., Kito H., Ando T., Goto M., Kuzushima K., Shibata M., Morishima T. Detection of viral DNA in neonatal herpes simplex virus infections: frequent and prolonged presence in serum and cerebrospinal fluid. J Infect Dis. 1991 Aug;164(2):289–293. doi: 10.1093/infdis/164.2.289. [DOI] [PubMed] [Google Scholar]
  27. Kumar M. L., Nankervis G. A., Cooper A. R., Gold E. Postnatally acquired cytomegalovirus infections in infants of CMV-excreting mothers. J Pediatr. 1984 May;104(5):669–673. doi: 10.1016/s0022-3476(84)80941-5. [DOI] [PubMed] [Google Scholar]
  28. Kwong A. D., Kruper J. A., Frenkel N. Herpes simplex virus virion host shutoff function. J Virol. 1988 Mar;62(3):912–921. doi: 10.1128/jvi.62.3.912-921.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Liljelund P., Ingles C. J., Greenblatt J. Altered promoter binding of the TATA box-binding factor induced by the transcriptional activation domain of VP16 and suppressed by TFIIA. Mol Gen Genet. 1993 Dec;241(5-6):694–699. doi: 10.1007/BF00279913. [DOI] [PubMed] [Google Scholar]
  30. Mazeron M. C., Jahn G., Plachter B. Monoclonal antibody E-13 (M-810) to human cytomegalovirus recognizes an epitope encoded by exon 2 of the major immediate early gene. J Gen Virol. 1992 Oct;73(Pt 10):2699–2703. doi: 10.1099/0022-1317-73-10-2699. [DOI] [PubMed] [Google Scholar]
  31. Michelson S., Alcami J., Kim S. J., Danielpour D., Bachelerie F., Picard L., Bessia C., Paya C., Virelizier J. L. Human cytomegalovirus infection induces transcription and secretion of transforming growth factor beta 1. J Virol. 1994 Sep;68(9):5730–5737. doi: 10.1128/jvi.68.9.5730-5737.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Nahmias A. J., Lee F. K., Beckman-Nahmias S. Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis Suppl. 1990;69:19–36. [PubMed] [Google Scholar]
  33. Nankervis G. A., Kumar M. L., Cox F. E., Gold E. A prospective study of maternal cytomegalovirus infection and its effect on the fetus. Am J Obstet Gynecol. 1984 Jun 15;149(4):435–440. doi: 10.1016/0002-9378(84)90159-5. [DOI] [PubMed] [Google Scholar]
  34. Pass R. F. Commentary: is there a role for prenatal diagnosis of congenital cytomegalovirus infection? Pediatr Infect Dis J. 1992 Aug;11(8):608–609. [PubMed] [Google Scholar]
  35. Porath A., McNutt R. A., Smiley L. M., Weigle K. A. Effectiveness and cost benefit of a proposed live cytomegalovirus vaccine in the prevention of congenital disease. Rev Infect Dis. 1990 Jan-Feb;12(1):31–40. doi: 10.1093/clinids/12.1.31. [DOI] [PubMed] [Google Scholar]
  36. Preston V. G., Davison A. J., Marsden H. S., Timbury M. C., Subak-Sharpe J. H., Wilkie N. M. Recombinants between herpes simplex virus types 1 and 2: analyses of genome structures and expression of immediate early polypeptides. J Virol. 1978 Nov;28(2):499–517. doi: 10.1128/jvi.28.2.499-517.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Saltzman R. L., Quirk M. R., Jordan M. C. Disseminated cytomegalovirus infection. Molecular analysis of virus and leukocyte interactions in viremia. J Clin Invest. 1988 Jan;81(1):75–81. doi: 10.1172/JCI113313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Shieh M. T., WuDunn D., Montgomery R. I., Esko J. D., Spear P. G. Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J Cell Biol. 1992 Mar;116(5):1273–1281. doi: 10.1083/jcb.116.5.1273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Sohn Y. M., Park K. I., Lee C., Han D. G., Lee W. Y. Congenital cytomegalovirus infection in Korean population with very high prevalence of maternal immunity. J Korean Med Sci. 1992 Mar;7(1):47–51. doi: 10.3346/jkms.1992.7.1.47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Stagno S., Pass R. F., Cloud G., Britt W. J., Henderson R. E., Walton P. D., Veren D. A., Page F., Alford C. A. Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA. 1986 Oct 10;256(14):1904–1908. [PubMed] [Google Scholar]
  41. Stagno S., Pass R. F., Dworsky M. E., Alford C. A., Jr Maternal cytomegalovirus infection and perinatal transmission. Clin Obstet Gynecol. 1982 Sep;25(3):563–576. doi: 10.1097/00003081-198209000-00014. [DOI] [PubMed] [Google Scholar]
  42. Stagno S., Pass R. F., Dworsky M. E., Henderson R. E., Moore E. G., Walton P. D., Alford C. A. Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection. N Engl J Med. 1982 Apr 22;306(16):945–949. doi: 10.1056/NEJM198204223061601. [DOI] [PubMed] [Google Scholar]
  43. Stern H., Tucker S. M. Prospective study of cytomegalovirus infection in pregnancy. Br Med J. 1973 May 5;2(5861):268–270. doi: 10.1136/bmj.2.5861.268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Sullender W. M., Miller J. L., Yasukawa L. L., Bradley J. S., Black S. B., Yeager A. S., Arvin A. M. Humoral and cell-mediated immunity in neonates with herpes simplex virus infection. J Infect Dis. 1987 Jan;155(1):28–37. doi: 10.1093/infdis/155.1.28. [DOI] [PubMed] [Google Scholar]
  45. Vial P., Torres-Pereyra J., Stagno S., González F., Donoso E., Alford C. A., Hirsch T., Rodríguez L. Estudio serológico para citomegalovirus, virus del herpes simple y de la rubeola, hepatitis B y Toxoplasma gondii en dos poblaciones de gestantes en Santiago, Chile. Bol Oficina Sanit Panam. 1985 Nov;99(5):528–538. [PubMed] [Google Scholar]
  46. Wahl S. M., McCartney-Francis N., Mergenhagen S. E. Inflammatory and immunomodulatory roles of TGF-beta. Immunol Today. 1989 Aug;10(8):258–261. doi: 10.1016/0167-5699(89)90136-9. [DOI] [PubMed] [Google Scholar]
  47. Wang P. S., Evans A. S. Prevalence of antibodies to Epstein-Barr virus and cytomegalovirus in sera from a group of children in the People's Republic of China. J Infect Dis. 1986 Jan;153(1):150–152. doi: 10.1093/infdis/153.1.150. [DOI] [PubMed] [Google Scholar]
  48. Whitley R., Arvin A., Prober C., Corey L., Burchett S., Plotkin S., Starr S., Jacobs R., Powell D., Nahmias A. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med. 1991 Feb 14;324(7):450–454. doi: 10.1056/NEJM199102143240704. [DOI] [PubMed] [Google Scholar]
  49. Zhang L. J., Hanff P., Rutherford C., Churchill W. H., Crumpacker C. S. Detection of human cytomegalovirus DNA, RNA, and antibody in normal donor blood. J Infect Dis. 1995 Apr;171(4):1002–1006. doi: 10.1093/infdis/171.4.1002. [DOI] [PubMed] [Google Scholar]
  50. van der Bij W., Torensma R., van Son W. J., Anema J., Schirm J., Tegzess A. M., The T. H. Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes. J Med Virol. 1988 Jun;25(2):179–188. doi: 10.1002/jmv.1890250208. [DOI] [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES